The association between the A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density (BMD) has been studied, but results have been mixed. Accordingly, the authors performed a meta-analysis on studies on the association between the A1330V LRP5 polymorphism and BMD. Appropriate studies were identified using MEDLINE and by manual searching. A total of 7 separate comparisons were considered in this meta-analysis. Individuals with the AA genotype showed significantly higher lumbar BMD than those with the AV/VV or VV genotype. Weighted mean differences (WMDs) were 0.147 g/cm(2) (95% confidence interval [CI] 0.069-0.224, P < 0.001) and 0.182 g/cm(2) (95% CI 0.024-0.340, P = 0.024) without between-study heterogeneity for AA versus AV/VV and AA versus VV, respectively. Six studies analyzed femur neck (FN) BMD. Individuals with the AA genotype had a significantly higher FN BMD than those with the AV/VV genotype (WMD = 0.165 g/cm(2), 95% CI = 0.087-0.215, P < 0.001), without between-study heterogeneity. Trochanter BMD was measured in three studies. Results showed that subjects with the AA genotype tended to have higher BMD than patients with the AV or VV genotype (WMD = 0.136 g/cm(2), 95% CI = -0.002 to 0.274, P = 0.053). In conclusion, this meta-analysis shows that the LRP5 A1330V polymorphism is associated with BMD, and that individuals with the AA genotype have a higher BMD than those with the AV/VV or VV genotype.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-008-0745-yDOI Listing

Publication Analysis

Top Keywords

g/cm2 95%
16
association a1330v
12
a1330v polymorphism
12
individuals genotype
12
genotype higher
12
bmd av/vv
12
av/vv genotype
12
higher bmd
12
bmd
9
polymorphism low-density
8

Similar Publications

Calcaneal bone mineral assessment in elite female trail runners.

J Clin Densitom

December 2024

INEFC-Barcelona Research Group on Sport Sciences (GRCE), National Institute of Physical Education of Catalonia (INEFC), University of Barcelona, Barcelona (UB), Spain. Electronic address:

This study aimed to assess the calcaneal bone mineral density (BMD) of elite female trail runners and evaluate its reliability using a novel DXA method. It also examined the relationship between calcaneal BMD and other regions of interest to better understand bone health in this specific population. A cross-sectional study was conducted with 35 elite female trail runners from the Spanish national team.

View Article and Find Full Text PDF

Design and commissioning of the PRIOR-II "proton microscope for FAIR".

Rev Sci Instrum

December 2024

Plasmaphysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Planckstrasse 1, 64291 Darmstadt, Germany.

A new high energy proton radiography facility PRIOR-II (Proton Microscope for FAIR) has been designed, constructed, and successfully commissioned at the GSI Helmholtzzentrum für Schwerionenforschung (Darmstadt, Germany) pushing the technical boundaries of charged particle radiography with normal conducting magnets to the limits. The setup is foreseen to become a new and powerful user facility for carrying out fundamental science experiments in the fields of plasma and shock wave physics, material science, and medical physics. It will help address several unsolved scientific challenges, which require high-speed and precise non-invasive diagnostic methods capable of probing matter with up to 100 g/cm2 areal density.

View Article and Find Full Text PDF

Context: Concentration of circulating anti-Müllerian hormone (AMH) predicts short-term (3-5 years) bone loss around menopause. Whether AMH during mid-reproductive years predicts bone health over a decade later is unknown.

Objective: To study the association of AMH levels in mid-reproductive years with bone density and turnover biomarkers measured after ∼14 years of follow-up.

View Article and Find Full Text PDF

Predictors of fracture in middle-aged and older adults with type 2 diabetes and overweight or obesity.

J Clin Endocrinol Metab

September 2024

J. Harold Harrison, MD, Distinguished University Chair in Rheumatology, Division of Rheumatology, Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.

Article Synopsis
  • Persons with type 2 diabetes have a higher fracture risk, which current assessment tools do not accurately reflect.
  • The study aimed to identify factors predicting fractures in individuals with type 2 diabetes who are overweight or obese, using data from a long-term clinical trial.
  • Significant findings revealed that use of thiazolidinedione and insulin medications increased fracture risk, while total hip bone mineral density was the strongest modifiable predictor, suggesting that BMD assessment should be incorporated in fracture risk evaluations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!